October 30, 2013 — Philips Healthcare and Infraredx Inc. announced a non-exclusive resale agreement for Infraredx’s TVC intravascular imaging system. Under the terms of the agreement, Philips will sell Infraredx’s TVC imaging system alongside its Allura interventional X-ray systems in North America and Europe, expanding its interventional cardiology portfolio of advanced live image-guidance solutions, clinical informatics and interventional tools.
The TVC imaging system is a first-in-class intravascular imaging system that integrates near-infrared spectroscopy lipid core plaque (LCP) detection technology, and intravascular ultrasound (IVUS) imaging to visualize the presence of plaques, quantify the degree of vessel stenosis and identify plaques prone to rupturing and causing dangerous blockages.
“Our goal is to further improve existing image-guided interventions and therapies and to enable new ones,” said Ronald Tabaksblat, general manager, interventional X-ray at Philips Healthcare. “By teaming up with Infraredx to sell the TVC imaging system, our product portfolio will be enhanced with an innovative intravascular imaging technology that works seamlessly with our interventional X-ray systems for better-informed treatment decisions and real-time therapy monitoring.”
“We’re pleased to partner with Philips, the leader in interventional X-ray systems, to expand access to our innovative TVC imaging system among Philips’ broad and established customer base in North America and Europe,” said Don Southard, president and CEO of Infraredx. “This resale agreement advances our global commercialization strategy by increasing our product’s penetration in the cardiac imaging market.”
Infraredx and Philips previously launched a software solution in March 2013 to enable the integration of the TVC imaging system with Philips’ Allura Xper and AlluraClarity interventional X-ray systems. The software enables an easy and quick setup of the TVC imaging system in conjunction with Philips’ Allura systems, and it allows clinicians tableside control of the TVC imaging system using the Allura system controls.
Clinicians can view a TVC composite image, which shows both the near-infrared spectroscopy image and the IVUS image, alongside the coronary angiogram on the Philips Allura monitors. The TVC composite image allows for better visualization of LCPs, which are known to cause complications in percutaneous coronary intervention (PCI) procedures and suspected of being the principal cause of most heart attacks.
For more information: www.healthcare.philips.com, www.infraredx.com